Long-term validation of AtherosSlerosis CardioVascular Disease (ASCVD) risk score and the role of aspirin for primary Cardiovascular prevention in Korean patients with over ASCVD 20% risk score
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

Seoul (Korea (Republic of))
7 More presentations in this session

Professor L. Zhong (Singapore, SG)

Doctor E. Steinacher (Vienna, AT)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024



